53
Research Trials
20
Peer-reviewed publications
16
Clinical Conditions
Hyfe pilot study tests a digital therapeutic combining passive cough monitoring with behavioral suppression techniques delivered through the CoughPro app.
This narrative review by Hyfe's R&D team makes the case that continuous cough monitoring (CCM), powered by acoustic AI, transforms cough from a subjective symptom into a quantifiable digital biomarker.
Independent ERS 2025 NeuroCOUGH trial uses the Hyfe Cough Tracker to test feasibility of studying azithromycin's effect on cough and oesophageal motility.
Independent ERS 2025 trial uses the Hyfe Cough Tracker to show azithromycin reduces objective cough frequency by week one in chronic respiratory disease.
Abstracts from the 2023 American Cough Conference: ACC2307: Validation of the Hyfe Cough Monitoring System" by Matthew Rudd, Isabel Sanchez-Olivieri, Sarah A R Siegel, and others,.
Authors: Matthew Rudd, Isabel Sa´nchez-Olivieri, Sarah A R Siegel, PeterM Small, Mindaugas Galvosas, Reid Moorsmith, Juan Pablo De Torres, Kevin L Winthrop, Carlos Chaccour
This abstract from the 2023 American Cough Conference: “ACC2307 - Validation of the Hyfe Cough Monitoring System” focuses on assessing the accuracy and reliability of the Hyfe Cough Monitor system. The system utilizes AI-powered capabilities for continuous and non-intrusive monitoring of coughs. The validation study aimed to establish a high correlation in the system's performance for both cough detection and cough duration measurement. This technology is expected to enhance patient care, aid cough research, and support drug development by providing precise and unobtrusive cough monitoring
